Decrease of Hepatitis C Burden in Patients With Transfusion Dependent Beta Thalassemia Major, Thalassemia Research Center, 1995 – 2014

Kosaryan, Mehrnoush; Aliasgharian, Aily

doi:10.17795/jpr-679

دوره 3، شماره 2 - ( 4-1394 ) جلد 3 شماره 2 صفحات 37-35 | برگشت به فهرست نسخه ها

‎ 10.17795/jpr-679

Mendeley

Zotero

RefWorks

Kosaryan M, Aliasgharian A. Decrease of Hepatitis C Burden in Patients With Transfusion Dependent Beta Thalassemia Major, Thalassemia Research Center, 1995 – 2014. J. Pediatr. Rev 2015; 3 (2) :35-37
URL: http://jpr.mazums.ac.ir/article-1-107-fa.html

Decrease of Hepatitis C Burden in Patients With Transfusion Dependent Beta Thalassemia Major, Thalassemia Research Center, 1995 – 2014. Journal of Pediatrics Review. 1394; 3 (2) :35-37

URL: http://jpr.mazums.ac.ir/article-1-107-fa.html

Decrease of Hepatitis C Burden in Patients With Transfusion Dependent Beta Thalassemia Major, Thalassemia Research Center, 1995 – 2014

چکیده: (4062 مشاهده)

Results: Screening for HCV started in 1995 at the TRC. Seventy-seven (15%) patients were antibody-positive in 1995. Tests for virus detection were not available at the time. Patients have been examined using serum AST, ALT, bilirubin, PT, PTT, and liver biopsy, and 45 were treated using alpha interferon alone. A second liver biopsy was performed at the end of treatment for 21 patients, and a blinded pathologist compared the histology according to the Knodell score. According to normalization of liver enzymes, the treatment was successful (McNemar test, P < 0.02). Based on the Knodell score, 54%, 31%, and 11% had complete, partial, and no response, respectively. A quantitative test for viremia became available thereafter. Thirteen patients who were resistant to alpha interferon have been treated using “Pegasys”™ ± ribavirin. Ten patients responded; however, three have been resistant and are still viremic. Twenty-seven patients received no treatment. Twenty-two (81.4%) had negative PCR tests. Five viremic patients refused treatment. A second screening test for HCV antibody was introduced in 2001, and, since then, annual screening for HCV antibody has been performed for all patients. No new case has been found since 2001. During the follow-up period, two deaths have been recorded in the cohort; none was a direct consequence of liver disease. Both patients had negative PCR tests for viremia. In 2014, there were 72 patients (52% men) with positive antibody tests, with a mean age of 30.5 ± 5.7 years. They mean age at the first blood transfusion was 2.8 ± 2.5 years. At the time of publishing, 15 patients (3.8%; 95% confidence interval 2 - 5.6) had viremia. Five patients had documented liver cirrhosis.

متن کامل [PDF 58 kb] (1757 دریافت)

نوع مطالعه: Original Article |
دریافت: 1393/11/25 | پذیرش: 1394/4/14 | انتشار: 1394/4/29

بازنشر اطلاعات
	این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Journal of Pediatrics Review می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

Designed & Developed by : Yektaweb

نظر شما در مورد قالب جدید چیست؟
	عالی
	خوب
	متوسط
	ضعیف

پایگاه های مرتبط

کلمات کلیدی

نظرسنجی